Systemic sclerosis & Raynaud's

Nailfold capillaroscopy as a predictor of major cardiovascular events and mortality in systemic sclerosis

Semin Arthritis RheumPublished Retrospective cohort study

Authors' conclusion

Avascular areas in baseline NFC are strong predictors of MCEs and mortality in SSc, whereas microhaemorrhages have a lower risk.

Study context

Population
Systemic sclerosis (SSc) patients diagnosed according to the 2013 ACR/EULAR criteria who underwent nailfold capillaroscopy (NFC) within one month of diagnosis
Participants
360 patients
Exposure
Baseline NFC findings as predictors of major cardiovascular events (MCEs) and mortality
Outcome
MCEs and mortality
Methodological detailsobservational, multivariable analyses
  • Observational
  • Multivariable analyses

Main finding

As reported in the abstract

Independent predictors of MCEs (multivariable) · median follow-up 11.7 years
MCE incidence
64 patients (17.8%)
Diabetes mellitus, HR
2.37, p = 0.031
ILD, HR
3.16, p < 0.001
Avascular areas on baseline NFC, HR
2.24, p = 0.034
Previous MCE, HR
3.89, p < 0.001
Microhaemorrhages (protective trend), HR
0.55, p = 0.053

Observational data: associations, not effects.

Further findings

Independent predictors of all-cause mortality (multivariable) · median follow-up 11.7 years

Overall mortality rate
21.1% (76 patients)
Deaths attributed to SSc-related complications / MCEs / other causes
30.9% / 29.4% / 39.7%
Age, HR
1.03, p = 0.039
Disease duration, HR
0.81, p < 0.001
Avascular areas, HR
2.09, p = 0.032
Microhaemorrhages (protective), HR
0.35, p = 0.002

SSc-related mortality

Avascular areas associated with poorer survival
log-rank p-value <0.001
Microhaemorrhages associated with better survival
log rank p-value = 0.01

Baseline NFC findings

Scleroderma NFC pattern
88%
Early / active / late pattern
33.05% / 32.5% / 22.5%
Giant capillaries
75.28%
Microhaemorrhages
54.17%
Avascular areas
38.6%

Original publication

Nailfold capillaroscopy as a predictor of major cardiovascular events and mortality in systemic sclerosis. Semin Arthritis Rheum. Published 5 October 2025. doi:10.1016/j.semarthrit.2025.152845

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.